Authors:
Schwartz, JI
Agrawal, NGB
Wong, PH
Bachmann, KA
Porras, AG
Miller, JL
Ebel, DL
Sack, MR
Holmes, GB
Redfern, JS
Gertz, BJ
Citation: Ji. Schwartz et al., Lack of pharmacokinetic interaction between rofecoxib and methotrexate in rheumatoid arthritis patients, J CLIN PHAR, 41(10), 2001, pp. 1120-1130
Authors:
Prueksaritanont, T
Vega, JM
Rogers, JD
Gagliano, K
Greenberg, HE
Gillen, L
Brucker, MJ
McLoughlin, D
Wong, PH
Waldman, SA
Citation: T. Prueksaritanont et al., Simvastatin does not affect CYP3A activity, quantified by the erythromycinbreath test and oral midazolam pharmacokinetics, in healthy male subjects, J CLIN PHAR, 40(11), 2000, pp. 1274-1279
Authors:
Van Hecken, A
Schwartz, JI
Depre, M
De Lepeleire, I
Dallob, A
Tanaka, W
Wynants, K
Buntinx, A
Arnout, J
Wong, PH
Ebel, DL
Gertz, BJ
De Schepper, PJ
Citation: A. Van Hecken et al., Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers, J CLIN PHAR, 40(10), 2000, pp. 1109-1120
Authors:
Van Hecken, A
Depre, M
Verbesselt, R
Wynants, K
De Lepeleire, I
Arnout, J
Wong, PH
Freeman, A
Holland, S
Gertz, B
De Schepper, PJ
Citation: A. Van Hecken et al., Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers, J CLIN PHAR, 39(5), 1999, pp. 495-500
Authors:
Kakuta, K
Tamai, H
Wong, PH
Kawahara, S
Tanaka, Y
Citation: K. Kakuta et al., Quantitative analysis of sequence length distribution of 1,2 units in polybutadienes by ozonolysis-GPC method, MACROMOLEC, 32(19), 1999, pp. 5994-5997